Kha Cong Le Bui

Dr. Kha Cong Le Bui

Department of Urology B, Hue Central Hospital, Huế, Thừa Thiên-Huế, Vietnam
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Kha Cong Le BuiKha Cong Le Bui
Kha Cong Le Bui
YDYen Thi Do
Yen Thi Do
JKJin Young Kim
Jin Young Kim
JSJi Hae Seo
Ji Hae Seo
Clear cell renal cell carcinoma (ccRCC) is increasingly recognized as a lipid-addicted malignancy in which de novo lipogenesis (DNL) supports tumor growth, survival, and treatment resistance. ccRCC-specific genetic alterations, particularly loss of VHL and activation of hypoxia-inducible factor (HIF) signaling, promote SREBP-mediated upregulation of key lipogenic enzymes, including ATP-citrate lyase (ACLY), acetyl-CoA carboxylase (ACC), fatty acid synthase (FASN), and stearoyl-CoA desaturase 1 (SCD1). These pathways support membrane biogenesis and redox balance while also promoting metabolic flexibility, enabling adaptation to therapeutic and microenvironmental stresses. Emerging preclinical studies suggest that pharmacological inhibition of lipogenic enzymes, either alone or in combination with tyrosine kinase inhibitors, mTOR inhibitors, HIF-2α antagonists, or immune checkpoint blockade, may suppress ccRCC progression. However, most therapeutic data remain limited to preclinical models, and clinical validation is still lacking. This review synthesizes recent advances in molecular regulation and therapeutic targeting of DNL in ccRCC and discusses the challenges and future opportunities to improve mechanistic understanding and explore potential therapeutic applications.

15 May 2024 in Cureus
Verified
Journal Article
Open access
NPNgoc Hung Pham
Ngoc Hung Pham
KPKhac Sang Phan
Khac Sang Phan
Kha Cong Le BuiKha Cong Le Bui
Kha Cong Le Bui
VNVan Quoc Anh Nguyen
Van Quoc Anh Nguyen
LLLuong Vinh Le
Luong Vinh Le
NTNgoc Khanh Tran
Ngoc Khanh Tran
Background: There are several types of benign renal diseases, such as urological stones, ureteropelvic junction obstruction, renal vascular disease, and inflammation, which are responsible for nonfunctioning kidneys. Laparoscopic nephrectomy (LN) is the gold standard for treating nonfunctioning kidneys with complications. This study presents the results of our initial experiences with 3D laparoscopic nephrectomy (3D-LN) for benign, nonfunctioning kidneys. Methods: From July 2021 to July 2023, 40 consecutive patients who underwent 3D transperitoneal laparoscopic nephrectomy were retrospectively evaluated at the Department of Urology and Department of General Surgery, Hue Central Hospital, Hue, Vietnam. Patient demographics, intraoperative and early postoperative results, postoperative recovery, complications, and three-month follow-up results were recorded. Results: The mean age was 58.35 +/- 14.9 years. There were 13 (32.5%) male and 27 (67.5%) female patients. Flank pain was the main reason for hospitalization in 33 cases (82.5%); the common cause of a nonfunctioning kidney was urological stones (62.5%). Twenty-three out of 40 patients underwent a left nephrectomy. The average operative time was 92.57 +/- 28.69 minutes. A statistically significant difference in surgery time was found between the group with no adhesion and the group with mild adhesion, as well as between the first 19 patients and the last 18 patients (p <0.05). The mean blood loss was 51.62 +/- 24.35 ml. Three cases were converted to open surgery due to severe adhesions. The postoperative complications rate was 8.1%. The average length of the postoperative hospital stay was 7.89 +/- 3.59 days. Conclusions: Three-dimensional laparoscopic nephrectomy is a safe and effective method that increases depth perception and spatial orientation for surgeons and can compensate for the remaining shortcomings of traditional 2D systems.

Verified
Journal Article
Open access
PDF file
YDYen Thi Do
Yen Thi Do
Kha Cong Le BuiKha Cong Le Bui
Kha Cong Le Bui
JKJin Young Kim
Jin Young Kim
SSSo-Jin Shin
So-Jin Shin
JSJi Hae Seo
Ji Hae Seo
Mitochondrial plasticity has emerged as a central determinant of cancer therapy response, enabling tumor cells to adapt to diverse metabolic, environmental, and therapeutic stresses. Among its key features, mitochondrial dynamics contributes to the balance between mitochondrial stress burden and compensatory capacity that shapes cell fate. We propose an adaptive-lethal threshold as a context-dependent conceptual framework describing the transition from reversible mitochondrial dynamics and cellular adaptation to persistent mitochondrial dysfunction and irreversible cell death commitment. Rather than representing a fixed molecular cutoff, this boundary reflects a context-dependent transition in which overall mitochondrial stress can no longer be adequately compensated to maintain cellular homeostasis. Furthermore, how this threshold is defined and reprogrammed in therapy resistance remains unresolved. In this review, we synthesize current advances to propose a framework in which mitochondrial dynamics govern cell fate through threshold-dependent mechanisms. We highlight key pathways across multiple cancer types, including reactive oxygen species (ROS) signaling, mitophagy, metabolic reprogramming, retrograde signaling, evasion of cell death, and interactions with the tumor microenvironment. Importantly, we discuss how context-dependent alterations in these processes can shift the balance between cytoprotective adaptation and irreversible mitochondrial dysfunction, contributing to therapy resistance or cell death. We further highlight emerging therapeutic strategies targeting mitochondrial dynamics and consider how modulation of mitochondrial dynamics can alter mitochondrial stress responses and influence the adaptive-lethal threshold, leading to cell sensitivity. Finally, we discuss key limitations and future directions in defining the context-dependent determinants of the adaptive-lethal transition and their implications for mitochondria-targeted therapies in cancer treatment.

3 November 2026 in Journal of Surgical Case Reports
Verified
Journal Article
Open access
KTKhanh N Tran
Khanh N Tran
TPThao N P Phan
Thao N P Phan
LNLiem T Ngo
Liem T Ngo
VLVinh L Le
Vinh L Le
LTLinh H Tran
Linh H Tran
Kha Cong Le BuiKha Cong Le Bui
Kha Cong Le Bui
Synchronous renal cell carcinoma (RCC) and upper tract urothelial carcinoma (UTUC) in one renal unit are rare and diagnostically challenging. A 52-year-old man with flank pain and hematuria had an enhancing renal mass, hydronephrosis, ureteral wall thickening, impaired excretion, and an obstructing ureteral stone. Magnetic resonance imaging suggested synchronous RCC and UTUC. Laparoscopic radical nephroureterectomy with bladder cuff excision and left renal hilar lymph-node sampling revealed WHO/ISUP grade 2 clear cell RCC (pT1aN0) and low-grade invasive UTUC (pT1N0). At 6 months, imaging and cystoscopic biopsies showed no recurrence. Imaging raised suspicion of synchronous malignancies, while histopathology confirmed both diagnoses and demonstrated less extensive UTUC than suggested radiologically.

1 February 2024 in Research and Reports in Urology
Verified
Journal Article
Open access
PDF file
NPNgoc Hung Pham
Ngoc Hung Pham
VHVuong Thang Hoang
Vuong Thang Hoang
Kha Cong Le BuiKha Cong Le Bui
Kha Cong Le Bui
Anh Nguyen Van QuocAnh Nguyen Van Quoc
Anh Nguyen Van Quoc
VTVan Can Truong
Van Can Truong
LHLance J Hampton
Lance J Hampton
Objective: Evaluation of the outcome of the miniaturized percutaneous nephrolithotomy in the treatment of nephrolithiasis with a lateral position based on the principle of a right triangle under the guidance of a C-Arm without contrast fluid. Materials and Methods: Sixty-nine cases of Mini-PCNL with the assistance of a vacuum-assisted sheath in the lateral position were performed at Central Hospital from March 2021 to August 2022. Percutaneous renal access was under the guidance of a non-rotational C-arm without contrast medium, and we determined the puncture location and depth of the needle based on the principle of right triangles. Results: The median age was 51.6 ± 12.5 years, and males accounted for 68.1% of the cases. 60.9% of all patients had normal weight. The median stone surface area was 361.1mm2, and 59.4% of all cases were graded as 2 regarding Guy’s stone score. The successful renal access rate was 100%. The tunnel access from the middle and lower calyx accounted for 94.2%. The median access duration, fluoroscopy duration, and hospital length of stay were 271.7 seconds, 14.79 seconds, and 6.3 days, respectively. The complete stone clearance rate was 78.3%. Bleeding complications occurred in 2 patients without mortality. Three patients required an additional procedure. Conclusion: The puncture technique into the renal calyxes based on the principle of the right triangle under the guidance of a non-rotational C-Arm without contrast medium in PCNL is a fast, exact, and safe technique.

11 November 2026 in Urology Case Reports
Verified
Journal Article
Open access
KTKhanh Ngoc Tran
Khanh Ngoc Tran
TPThao Nguyen Phuong Phan
Thao Nguyen Phuong Phan
LNLiem Thanh Ngo
Liem Thanh Ngo
VLVinh Luong Le
Vinh Luong Le
APAn Duy Phan
An Duy Phan
Kha Cong Le BuiKha Cong Le Bui
Kha Cong Le Bui